A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2002
11/19/2002	US6482846 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/19/2002	US6482825 Growth-hormone secretagogues
11/19/2002	US6482810 Antibiotic composition for inhibition of angiogenesis
11/19/2002	US6482802 Use of neomycin for treating angiogenesis-related diseases
11/19/2002	US6482800 Methods to stimulate angiogenesis
11/19/2002	US6482798 Aprotinin variants having a net charge of +3 to -3 at ph 7 and with the amino acids arg15 or arg15-ala17 in the binding region; serine protease inhibitor
11/19/2002	US6482797 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ACE)
11/19/2002	US6482796 Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
11/19/2002	US6482795 Tumor suppressor designated TS10q23.3
11/19/2002	US6482644 Antisense modulation of dual specific phosphatase 8 expression
11/19/2002	US6482626 Human DNase
11/19/2002	US6482623 Lipid kinase
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482616 RCA-free adenoviral vector system and propagation method
11/19/2002	US6482613 Microbial production of mature human leukocyte interferons
11/19/2002	US6482612 Adipocyte-specific protein homologs
11/19/2002	US6482609 Isolated human EDG-4 receptor and polynucletide encoding said receptor
11/19/2002	US6482608 Cloning and recombinant production of CRF receptor(S)
11/19/2002	US6482605 Protein tyrosine phosphatase PTP20 and related products and methods
11/19/2002	US6482598 Antibody recognizing a small subset of human hematopoietic cells
11/19/2002	US6482597 Compounds and methods for therapy and diagnosis of lung cancer
11/19/2002	US6482586 Hybrid compositions for intracellular targeting
11/19/2002	US6482517 Coated particles, methods of making and using
11/19/2002	US6482435 Temperature sensitive gel for sustained delivery of protein drugs
11/19/2002	US6482416 Alteration of macrophage-induced t cell suppression or concentration by the selective elimination or increase of tryptophan by administering an enzyme inhibitor of indole-amino 2,3-deoxygenase; viricides; abortion; fertility;
11/19/2002	US6482412 Actinomyces used to biosynthesize polypeptide to treat aids
11/19/2002	US6482411 Osteoporosis
11/19/2002	US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002	US6482409 Treatment for inflammatory bowel disease with a vcam-1/1gG fusion protein
11/19/2002	US6482408 Fibroblast growth factor 15 antibodies
11/19/2002	US6482405 Antitumor
11/19/2002	US6482403 Caniney IL-13 immunoregulatory proteins and uses thereof
11/19/2002	US6482396 Combination of lactoferrin (lf) and glycomacropeptide (gmp) that exerts an antimicrobial effect in oral cavities
11/19/2002	US6481065 Jewelry closure
11/19/2002	CA2332631C Soft gelatin capsule manufacture
11/19/2002	CA2312667C Novel cytokine
11/19/2002	CA2272990C Heptapeptide oxytocin analogues
11/19/2002	CA2261579C Isolated peptides derived from mage-2
11/19/2002	CA2216870C Compositions and methods for regulating hair growth
11/19/2002	CA2155931C Inhibitors of thrombosis
11/19/2002	CA2153546C Periwinkle grain extract and composition containing the same
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002	CA2086101C Immune suppressive product from milk
11/19/2002	CA2044143C Method of preventing or limiting reperfusion damage
11/19/2002	CA1341399C Intercellular adhesion molecules and their binding ligands
11/19/2002	CA1341398C Expression of biologically active pdgf analogs in eucaryotic cells
11/18/2002	CA2366810A1 The treatment of anorexia nervosa and bulimia
11/15/2002	WO2001088149A1 Polypeptides cleaving telomeric repeats
11/15/2002	CA2410974A1 Polypeptides cleaving telomeric repeats
11/14/2002	WO2002090991A2 Proteins and genes for diagnosis and treatment of erbb2-related cancer
11/14/2002	WO2002090986A1 Colon cancer antigen panel
11/14/2002	WO2002090974A2 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090595A1 Methods for modulating an immune response by modulating krc activity
11/14/2002	WO2002090594A1 Antisense modulation of phospholipase a2, group vi (ca2+-independent) expression
11/14/2002	WO2002090591A1 Antisense modulation of interleukin 12 p40 subunit expression
11/14/2002	WO2002090590A1 Antisense modulation of interleukin 12 p35 subunit expression
11/14/2002	WO2002090585A2 Genetic polymorphism pattern of tgfb1 as marker for susceptability to renal disease
11/14/2002	WO2002090583A2 Skin treatment
11/14/2002	WO2002090578A2 Methods and means of histone methylation
11/14/2002	WO2002090576A1 Methods and compositions for the treatment and diagnosis of body weight disorders
11/14/2002	WO2002090571A2 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090566A2 Recombinant tumor specific antibody and use thereof
11/14/2002	WO2002090553A2 Recombinant fusion proteins and the trimers thereof
11/14/2002	WO2002090552A2 Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing
11/14/2002	WO2002090551A2 Self-containing lactococcus strain
11/14/2002	WO2002090548A1 Method of purifying chromosomal dna replication initiating protein dnaa of pathogenic bacterium using affinity of dnaa protein for atp, method of evaluating antibacterial activity and method of screening compound having antibacterial activity using affinity of dnaa protein for atp
11/14/2002	WO2002090546A1 Polypeptide serving as angiogenic marker and dna thereof
11/14/2002	WO2002090545A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
11/14/2002	WO2002090544A2 Protein-protein interactions in adipocyte cells (3)
11/14/2002	WO2002090543A2 Regulation of human phosphatidic acid phosphatase type 2c-like protein
11/14/2002	WO2002090542A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090526A2 Human secreted proteins
11/14/2002	WO2002090525A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/14/2002	WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090519A2 Mutant p21?cip1/waf1¿ and cell growth control
11/14/2002	WO2002090518A2 Differential regulation of t cell survival and proliferation
11/14/2002	WO2002090514A2 Epidermal growth factor receptorantisense oligonucleotides
11/14/2002	WO2002090507A2 Oligonucleotide inhibitors of cancer cell proliferation
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090503A2 Anti-microbial peptides and compositions
11/14/2002	WO2002090500A2 Novel human proteins, polynucleotides encoding them and methods of using the same
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090495A2 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	WO2002090494A2 Isolation, characterization, cloning and use of a mushroom lectin
11/14/2002	WO2002090493A2 Δ4-desaturase genes and uses thereof
11/14/2002	WO2002090388A1 Derivatives of exendin
11/14/2002	WO2002090385A1 Protein polymer having unfold activity on higher-order structure of protein
11/14/2002	WO2002090384A2 Antimicrobial polypeptide from aspergillus niger
11/14/2002	WO2002090381A1 Chemokine-binding proteins for treating congestive heart failure
11/14/2002	WO2002090380A1 Tetrapeptide stimulating the retinal function and the method of its application
11/14/2002	WO2002090379A1 Process for inactivating prions in lipoproteins
11/14/2002	WO2002090377A2 Peptides that bind to dna and inhibit dna replication, and methods of use
11/14/2002	WO2002090376A1 Lectin protein prepared from korean marine crab philyra pisum, process for preparing the same and the use thereof
11/14/2002	WO2002090373A1 Human sperm activator peptides
11/14/2002	WO2002090361A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic

1 ... 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 ... 3163